Inhaled corticosteroids in COPD: Systemic effects of a local therapy?

Expert Opinion on Pharmacotherapy

Volumn 9, Issue 18, 2008, Pages 3271-3273

  Antoniu, Sabina A ^a  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

combined inhaled therapy; COPD; inhaled corticosteroids; systemic inflammation

Indexed keywords

EID: 77952539828     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656560802591406     Document Type: Article

References (9)

1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. The GOLD Workshop Report (updated 2007). Available from: www.goldcopd.com (October 2008)
2. Antoniu SA, Mihaescu T, Donner CF. Inhaled therapy for stable chronic obstructive pulmonary disease. Expert Opin Pharmacother 2007;8(6):777-85
3. Antoniu S, Donner CF. Fluticasone propionate in COPD airway inflammation: there is a partial effect? Expert Rev Pharmacoecon Outcomes Res 2002;2(5):415-7
4. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356(8):775-89
5. Sin DD, Man SF, Marciniuk DD, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177(11):1207-14
6. Hattotuwa KL, Gizycki MJ, Ansari TW, et al. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study. Am J Respir Crit Care Med 2002;165(12):1592-6
7. Gizycki MJ, Hattotuwa KL, Barnes N, et al. Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue. Thorax 2002;57(9):799-803
8. Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med 2006;173(7):736-43
9. Sin DD, Lacy P, York E, et al. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170(7):760-5.